James Trager - Aug 15, 2022 Form 4 Insider Report for Nkarta, Inc. (NKTX)

Role
Chief Scientific Officer
Signature
/s/ Alicia Hager, as Attorney-in-Fact
Stock symbol
NKTX
Transactions as of
Aug 15, 2022
Transactions value $
-$68,206
Form type
4
Date filed
8/17/2022, 04:21 PM
Previous filing
Jun 21, 2022
Next filing
Jan 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NKTX Common Stock Options Exercise $19.5K +5K +8.04% $3.89 67.2K Aug 15, 2022 Direct F1
transaction NKTX Common Stock Sale -$87.7K -5K -7.44% $17.53* 62.2K Aug 15, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NKTX Stock Option (right to buy) Options Exercise $0 -5K -5.36% $0.00 88.2K Aug 15, 2022 Common Stock 5K $3.89 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person at least 30 days prior to the trade date.
F2 This transaction was executed in multiple trades at prices ranging from $17.50 to $17.62. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on September 5, 2023.